ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0750
-0.0002 (-0.27%)
At close: Jun 18, 2026
ProPhase Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.35 | 6.77 | 34.98 | 122.65 | 79.04 | |
Revenue Growth (YoY) | -35.82% | -80.65% | -71.48% | 55.17% | 444.59% |
Cost of Revenue | 2.96 | 6.92 | 19.43 | 51.99 | 37.05 |
Gross Profit | 1.38 | -0.15 | 15.56 | 70.65 | 41.99 |
Selling, General & Admin | 19.32 | 37.89 | 33.44 | 34.39 | 22.49 |
Research & Development | 0.11 | 0.59 | 3.33 | 12.67 | 9.69 |
Operating Expenses | 19.43 | 38.48 | 36.78 | 47.06 | 32.19 |
Operating Income | -18.05 | -38.63 | -21.22 | 23.6 | 9.8 |
Interest Expense | -6.93 | -3.35 | -1.27 | -0.76 | -1.15 |
Interest & Investment Income | - | - | 0.06 | 0.51 | 0.81 |
Earnings From Equity Investments | -0.17 | - | - | - | - |
Other Non Operating Income (Expenses) | 1.88 | -0.02 | 0.01 | - | - |
EBT Excluding Unusual Items | -23.27 | -42 | -22.42 | 23.34 | 9.46 |
Gain (Loss) on Sale of Investments | - | - | 0.02 | -0.43 | -0.41 |
Gain (Loss) on Sale of Assets | -0.96 | - | - | - | - |
Other Unusual Items | 0.84 | -0.33 | - | - | -3.75 |
Pretax Income | -23.39 | -42.33 | -22.4 | 22.91 | 5.31 |
Income Tax Expense | - | 7.2 | -6.02 | 4.45 | -0.97 |
Earnings From Continuing Operations | -23.39 | -49.53 | -16.38 | 18.46 | 6.27 |
Earnings From Discontinued Operations | 8.64 | -3.84 | -0.4 | - | - |
Net Income | -14.74 | -53.36 | -16.78 | 18.46 | 6.27 |
Net Income to Common | -14.74 | -53.36 | -16.78 | 18.46 | 6.27 |
Net Income Growth | - | - | - | 194.32% | - |
Shares Outstanding (Basic) | 8 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 8 | 2 | 2 | 2 | 2 |
Shares Change (YoY) | 324.45% | 16.23% | -7.74% | 1.40% | 58.63% |
EPS (Basic) | -1.74 | -26.68 | -9.75 | 11.65 | 4.13 |
EPS (Diluted) | -1.74 | -26.68 | -9.75 | 10.24 | 3.95 |
EPS Growth | - | - | - | 158.92% | - |
Free Cash Flow | -8.34 | -18.44 | -13.97 | 24.63 | -17.85 |
Free Cash Flow Per Share | -0.98 | -9.22 | -8.12 | 13.21 | -9.71 |
Gross Margin | 31.85% | -2.22% | 44.47% | 57.61% | 53.12% |
Operating Margin | -415.35% | -570.59% | -60.66% | 19.24% | 12.40% |
Profit Margin | -339.31% | -788.24% | -47.97% | 15.05% | 7.94% |
Free Cash Flow Margin | -192.04% | -272.44% | -39.94% | 20.08% | -22.58% |
EBITDA | -13.22 | -32.44 | -15.17 | 28.31 | 13.04 |
EBITDA Margin | - | - | -43.36% | 23.09% | 16.49% |
D&A For EBITDA | 4.83 | 6.19 | 6.05 | 4.72 | 3.23 |
EBIT | -18.05 | -38.63 | -21.22 | 23.6 | 9.8 |
EBIT Margin | - | - | -60.66% | 19.24% | 12.40% |
Effective Tax Rate | - | - | - | 19.40% | - |
Advertising Expenses | 0.01 | 0.34 | 1.8 | 0.4 | 0.4 |